chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since I have gotten it, I have had massive hair loss; Hair has become very dry and brittle; Hair has become very dry and brittle; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 37 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 05May2021 (Lot number: ER8735) at the age of 37 years as dose 2, single and intramuscular, administered in arm, administration date 14Apr2021 (Lot number: EP7534) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "not recovered", described as "Since I have gotten it, I have had massive hair loss"; HAIR TEXTURE ABNORMAL (non-serious), TRICHORRHEXIS (non-serious) all with onset 2021, outcome "not recovered" and all described as "Hair has become very dry and brittle". Therapeutic measures were not taken as a result of alopecia. Therapeutic measures were taken as a result of hair texture abnormal, trichorrhexis.  Additional Information: Vaccination facility type was reported as Doctor's Office/Urgent care. Prior vaccination (before 4 weeks) was reported as no. Anatomical site of injection for both doses of vaccine was reported as upper arm. Consumer stated, "I just wanted to report a adverse effect from the vaccine. Since I have gotten it, I have had massive hair loss. I have experience extreme hair loss 4-5 months and continuing after have both my covid shots. What can I do to fix this. My hair has become very dry and brittle no matter what I put in it. It's not helping." Investigation assessment was reported as no. Relevant tests were reported as None. Specific relevant test for thromboembolic events with thrombocytopenia was reported as None.  Follow-up attempts are completed. No further information is expected.
Pt. awakened 10/24/06 @ 5am. After shower body was more red than usual.  On drive to work, pt felt uncomfortable, felt heat and pressure on chest and back. Skin felt itchy. At work, coworkers advised her she was "red". Called office at 8:15am. No c/o difficulty swallowing, no coughing. Advised to see MD now. Temp. 98.6, P 72, B/P 117/70. MD administered Kenalog IM, told to take Benadryl po at home and if symptoms worsened or not resolving to go to ED.
Tiredness, fatigue after shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 21Nov2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Nov2021, outcome "unknown", described as "Tiredness, fatigue after shot".  Additional information: NDC number was not provided. Investigation assessment was not reported.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever, vomiting evening of immunizations. Mother took to physician. Family physician believes he had more immunization than child could handle at one time.
An adult female patient, age unspecified , experienced diarrhea, severe fatigue, severe headache, nausea, fever (up to 100.2 F), chills, swollen joints and constant throbbing pain from the top of her head down the back of her legs, after receiving post-exposure treatment with RabAvert following exposure to animals in a petting zoo. The patient received her first RabAvert dose on 08/06/2004, the second on 08/09/2004, the thrid on 08/14/2004, the fourth on 08/21/2004 and the fifth on 09/04/2004. The patient was present at a petting zoo on 07/24/2004. She noticed an animal that did not look well but thought it was dehydrated due to the heat. Later a friend notified her that it was reported on the local news that anyone who was in the zoo between 07/13/2004 and 07/30/2004 should be treated for rabies because some of the animals were found to have rabies. After the first dose of RabAvert on 08/06/2004 the patient experienced headache, nausea, body aches, joint aches, muscle aches and fevers up to 100.2 F. She called her physician and was told these were typical symtoms. On 09/12/2004 she went to the emergency room because she was getting any better. Blood, urine tests and a chest x-ray were performed and the results reported as normal. She was taking Tylnol and Motrin without relief. On 09/13/2004 her family physician treated her with Vitamin B complex and gave her a prescription for Lortab, Phenergan and Glucofac-ZX (high potency vitamins) and referred her for an infectious disease specialist, who then referred her to the state health department. She was subsequently referred to Chiron because they were not familiar with rabies. At the time of this report the patient had not recovered from her symptoms with the exception of fever with chills and diarrhea which had improved without medication. She was still waiting for the results of the blood tests that were sent for analysis. She was concerned about not being able to work because her decreased performance staus due to constant fatigue and the other reported symtoms.
GOT SICK; This spontaneous report received from a patient via a company representative via social media concerned a 50 year old male of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: patient was healthy. The patient previously received covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of administration, batch number were not reported, expiry: unknown) 1 total, dose was not reported, start therapy date was not reported for prophylactic vaccination.  On an unspecified date, the patient got sick (dose number in series 1).  The patient additionally received booster covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient got sick (dose number in series 2). Patient reported, "I am I healthy 50 year old male had the covid Shots got sick the second time around worst than the first time the only reason I got the shots was because of the job I am out.now and will.never again get these shots this is bullcrap I would not recommend anybody getting these shots nobody ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got sick was not reported. This report was non-serious. This case, involving the same patient is linked to 20220661192.
This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis. Co-suspect products included PNEUMOCOCCAL PNEUMONIA VACCINE for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose and PNEUMOCOCCAL PNEUMONIA VACCINE. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant), pneumonia (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure, pneumonia and influenza were unknown. It was unknown if the reporter considered the vaccination failure, pneumonia and influenza to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. After vaccination, the patient experienced flu and also pneumonia. The reporter did not think, the reporter would no more bother. This case was considered as suspected vaccination failure as details regarding time to onset for target disease, time to onset and laboratory confirmation were unknown.
High fever of 103.3, sustained high fever of 100.5 for 48 hours, chills, headache
This patient was fully vaccinated (Moderna 12/29/20 & 1/28/21) and tested positive for COVID-19 on 8/15/21. She was hospitalized for 2-3 days while symptomatic. She has a history of CVA 6 years prior and developed significant headache w/ nausea vomiting on 8/13/21. This worsened and she was seen in the ER on 8/15/21 to rule out CVA. She was admitted for further testing  and Neurological consult. While hospitalized she tested (+) for COVID-19. She did not develop any respiratory symptoms and denies any SOB, cough, or congestion. Her symptoms have since improved and she is currently home under isolation with no further complaints.
9/9/21 pt brought to ED and admitted with severe FTT over the past 9 months; noncompliant with doctor's follow ups; refused to see a dr in the past; admitted; found to be positive for COVID; severe dysphagia; 50 pound weight loss in 2 months; pt not requiring O2 supplement; found to have right peritonsillar mass; bx done; squamous cell carcinoma posterior pharyngeal wall and hypopharynx; not a candidate for surgery; PEG tube placed; dc'd from hospital to facility; records show pt passed away at home on 11/21/21
Onset about 14 hours after vaccine... severe myalgias... fever of 101.5. Resolved after 26 hours of vaccine second dose.
6/12 45 y/o male with medical history significant for seizures post TBI from MVA, HTN, who presented to the hospital for 3 episodes of break through seizures.
Individual was administered Pfizer Bivalent vaccine on March 30, 2023, then on May 12, 2023, she was administered Moderna Bivalent. COVID Vaccine. Individual was administered vaccine weeks prior to 4 months recommended interval.
I experienced pain with the injection of the medication - the needle did not hurt, but there was terrible burning for 2-3 min following the injection, in the right arm (extreme upper right arm). I experienced pain at the injection site and my arm was very achy and weak for 2 1/2 weeks. Now, 3 weeks after the injection my arm is not nearly as sore, but I still feel pain at the injection site and with certain movements.
Pt after onset of shots about 15 minutes c/o rash, hives then SOB. Pt given EPIPEN 0.3mg - IM & PO BENADRYL 25mg liquid & assessed. 911 called due to SOB. Pt transferred to ER for assessment.
Information was received from a registered nurse referring to a 17 years old female patient. The patient had neither medical history, concomitant therapy nor known drug allergies. In the afternoon of 25-JUL-2016, the patient received a dose (dose number unspecified) of GARDASIL 9 injection intramuscularly (lot# M009362, expire date was 13-JUN-2018). On 26-JUL-2016 the patient woke up with tongue swelling and a systemic rash. She visited the physician on the same day, and was advised to take an unspecified dose of oral BENADRYL. On 28-JUL-2016, the patient was evaluated at an unspecified Urgent Care facility (demographics unknown) and had a tested for Strep (result unknown). She was administered an unspecified amount of an unspecified intravenous solution and an unspecified amount of SOLU-MEDROL. The unspecified Urgent Care facility prescribed SOLU-MEDROL (45mg, once daily, oral), prednisone (manufacturer unknown) for 3 days and an unspecified amount of oral BENADRYL as needed for an unspecified symptom. On 29-JUL-2016, tongue swelling improved in an unspecified improvement and the unspecified rash improved for an unspecified amount of time after each dose of prednisone (manufacturer unknown) taking. The reporter considered that the events were life threatening or significant disability or incapacity due to the patient's tongue affected. Additional information has been requested.
c/o muscle aches, bruise on chest, high heart rate and no appetite. On 5/3/21 see a Primary Care in and had a heartrate of 145.
I have had a severe headache since the day of vaccination, weakness, fatigue, dizziness, vomiting and diarrhea.
Fever of 102.5, swelling in left arm with redness exceeding three inches by 2 inches in left arm, chills, extreme fatigue
Patient's daughter called the pharmacy 2 days after administration of vaccine about adverse reaction. Patient started feeling unwell about 3 hours after administration, feeling dizzy,  hives, shortness of breath, Patient went to the hospital and was monitored. Patient has since been released and today he is feeling fine.
Rash under left armpit to center chest and upper back. Painful and itchy. Presenting 9 days after administration then again 14 days after with worsening. Treated with valacyclovir and Hydroxyzine.
she had pfizer as a first dose, she had a relapse with her disease/autoimmune disease; she had pfizer as a first dose, she had a relapse with her disease/autoimmune disease; This is a spontaneous report from a contactable consumer (patient) based on information received by Pfizer, on behalf of Moderna (manufacturer control number: MOD21-162759). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation.  The patient medical history included autoimmune disease. Concomitant medications were not reported. The patient had autoimmune disease. She had Pfizer as a first dose, but two weeks after she had a relapse with her disease and landed in the ER. She said that she thinks this is related to the vaccine and that's why she chose Moderna as a second dose. The outcome was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a registered nurse, referring to multiple unspecified patients of unknown age and gender. No medical history and concurrent conditions of the patients were reported. On an unknown date, unspecified number of patients were vaccinated with improperly stored doses of ROTATEQ (lot # K013861, expiration date 18-MAY-2016; lot # K0201811, expiration date 24-JUN-2016; dose was not reported). No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Mildly painful, flat red rash, severe itching on scalp, arms, armpits, upper torso and neck that comes and goes. Rash is also present on face and left deltoid shoulder without itching. Intermittent pain in left deltoid. High blood pressure 156/100. Severe itching on abdomen without rash. Floaters and flash in vision on 12/17/2021.
This spontaneous report was received from a registered nurse referring to a patient of currently 1 year age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of (Merck) VARIVAX with lot # L009205, expiry date 17-MAR-2017; dose, route of administration and anatomical location not reported). The doses of (Merck) VARIVAX underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There were no previous temperature excursions. No symptoms were reported. No product quality complaint (PQC) was involved. No further information provided. This is one of several reports from the same reporter. Additional information has been requested.
With a week or 10 days I noticed swelling between legs between ankle and knee and my veins are swollen
Patient developed full blown head to toe chickenpox (>100 lesions) 5 days after the vaccine was given. Fevers 101-102. Patient's symptoms were managed, no antivirals given.
Patient had difficulty breathing, throat starting to swell, difficult to swallow, EpiPen given X 2
after recieving the vaccination the patient had fever blisters appear around the entirety of her top and bottom lips of her face.
Pt received Dtap (L) deltoid on 2/25/13. Patient c/o redness / swelling / itching that worsened on 2/27/13. On exam 2/27/13 skin on (L) upper arm with large area of warmth, erythema with puncture seen at upper pole, approx 10 x 8 cm nontender minimal streaking (border down) Dx cellulitis Rx clindamycin 150 mg TID x 10 days. Reexamined 3/1/13 with faint area of erythema, no extension of redness, no induration or tenderness.
Administered 1mL doses instead of 0.5mL dose; A spontaneous report was received from a nurse concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered 1mL dose instead of 0.5mL dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 29 Dec 2020, after vaccine administration, the nurse called to report that the patient had been administered a 1mL dose instead of 0.5mL dose of the vaccine. No side effects were reported due to the event. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The event, administered 1mL dose instead of 0.5mL dose, was considered resolved on 29 Dec 2020.; Reporter's Comments: This case concerns a patient of unknown age and gender The patient's medical history is not provided. The patient experienced an unexpected event of inappropriate dose of vaccine administered (1ml instead of recommended 0.5ml).  The event occurred on 29 Dec 2020 during the administration of first dose of mRNA-1273. The patient did not have any side effects. The sponsor considered the event as not related to mRNA-1273.
Hardness, swelling, sensitive, and hotter than body temp at source of injection on affected area. Fever and nasal congestion. Reaction to yellow fever site only.
This spontaneous report as received from a registered nurse refers to an unspecified patients (demographics unknown). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose, route and lot# were not reported) which this single dose was exposed to -1C for 22 days. The nurse stated that she was not sure if dose may had been administered to the patient. No adverse effects reported. Follow-up information has been received from the registered nurse and refers to a 59 years old male patient. On 15-MAY-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (dose and route were not reported, lot # K003074, expiration date 13-MAR-2015) that was stored improperly. The diluent was exposed to lower than 2C for more than 15 days, the lowest temperature was -1C for 5 days. No symptoms were reported. No PQC (product quality complaint) involved. The reporter asked if the patient had to be revaccinated. This is one of several reports from the same source. Additional information has been requested.
COVID arm - Client stated that his arm became red swollen, hot to the touch, in the arm that received the injection. Client stated that it lasted about a week.
Itchy rash on thighs, buttocks, and back of calves. If it worsens, I'll go to a dr, but right now just treating with cortisone cream.
A report was received from a health care professional on 2/24/04 concerning up to 8 vaccinees under 4 years of age and of unknown gender who inadvertently received a dose of Fluvirin vaccine on an unreported day in December 2003. On an unspecified day in December 2003, up to 8 vaccinees were inadvertently administered Fluvirin. The outcome of the event was not reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/22/04: Further information was received from a health care professional indicating that the vaccinee was 47 month old female who inadvertently received 0.5ml Fluvirin on 12/10/03. No adverse events were reported at the time of the event. No follow up pending. All information received.
incorrect  pfizer covid 19 vaccine administered - should have been pfizer covid 19 bivalent vaccine
Burning in the arm (shot was sub derma) at first.  Next day there was a lump at injection area.  very tired for two days and felt feverish/flu like.  Second shot was two weeks later (in the mussel) and felt very tired the next day could not run more than 7 minutes at a time usually run for 30 minutes
After waiting 15 minutes in the observation room, I left as I was feeling fine.  About 10 minutes later, as I was driving home, I had an odd taste in my mouth and my right cheek started to go numb.  I arrived home and started looking for answers (Pfizer information page that lists side effects).  The sensation lasted about an hour or so, then started to subside.  By the time I went to bed, there was just a little tingle at the edge of my cheek bone. Other than being tired and a bit woozy, I feel better today.
Burning up, nauseous,  loss of appetite,  enlarged lymph nodes under left arm, swollen glands in neck, pain in both injection sites on both arms, aches throughout whole body.
consumer reports that daughter recv hib/dtp/opv at age 2 months, devel. diarrhea for 7 days.  recv vax again at age 4 months and devel diarrhea.
Flue like symptoms, dizzy,  aches in shoulders joints,  chills and fever for several hours. took two  500 mg acdmediphane tablets at 2AM.
Pt very sick; 17JAN92 dx meningitis/encephalitis; pt recvd vax on 13FEB91; On 20, 23 & 24FEB92 had a sl fever w/no other sx; On 26FEB91 @ 430PM mom noted pt looked dazed, pt did not respond; began sz & stopped breathing, CPR, cardiac arrest
8/14/19-received 1st round of shingrix and left feeling tired, shaky, feverish for 1 to 2 weeks 9/17/19- started to feel low 9/19/19- felt ear pain 9/23/19- went to the doctor and got an antibiotic for ear infection 9/25/19- went back to the doctor and was told I had shingles inside the ear. Doctor mentioned it was a mild case and it can take 6 weeks to recover.
This spontaneous report as received from a nurse refers to a 6 month old patient of unknown gender. On 26-JAN-2015, the patient was vaccinated with improperly stored oral ROTATEQ (either lot # K007247 and expiry date: 17-MAR-2016 or lot# K006805 and expiry date: 24-MAR-2016). No adverse events were reported. No product quality complaint (PQC) was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
fever and headache 5 hours after taking shot. Fever and headache lasted roughly 30 hours. Three days after taking shot started to itch real bad and have hive like bumps. Currently still have itching bumps 4 days after shot